LindaRN_retired said:The glucagon component looks paradoxical and is not.
Genuinely useful, thank you. I had the facts and not the framework. Adding it to my notes with a link back to this thread.
Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
Happy to go further on any of that.
Dr.NateNeph said:The distinction that resolves most of these threads is between what is true on average and what is true for one person.
Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemOne concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.
Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.